QQ客服 官方微博 反馈留言

浏览/检索结果: 共9条，第1-9条 帮助 限定条件 发表日期：2018     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Circulating Tumor DNA as a Sensitive Marker in Patients Undergoing Irreversible Electroporation for Pancreatic Cancer 期刊论文 CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 卷号: 47, 期号: 4 作者:  Lin, Mao;  Alnaggar, Mohammed;  Liang, Shuzhen;  Chen, Jibing;  Xu, Kecheng 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 Circulating tumor DNA  KRAS  Pancreatic ductal adenocarcinoma  Overall survival  Droplet digital polymerase chain reaction   Circulating Tumor DNA as a Sensitive Marker in Patients Undergoing Irreversible Electroporation for Pancreatic Cancer (vol 47, pg 1556, 2018) 期刊论文 CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 卷号: 48, 期号: 3 作者:  Li, Mao;  Alnaggar, Mohammed;  Liang, Shuzhen;  Chen, Jibing;  Xu, Kecheng 收藏  |  浏览/下载：14/0  |  提交时间：2019/12/05 Circulating Tumor DNA as a Sensitive Marker in Patients Undergoing Irreversible Electroporation for Pancreatic Cancer 期刊论文 2018, 卷号: 47, 期号: 4, 页码: 1556 作者:  Lin, Mao[1,2];  Alnaggar, Mohammed[3,4,5];  Liang, Shuzhen[1,2];  Chen, Jibing[1,2];  Xu, Kecheng[1,2] 收藏  |  浏览/下载：18/0  |  提交时间：2019/12/10 Irreversible electroporation of malignant liver tumors: Effect on laboratory values 期刊论文 2018, 卷号: 16, 期号: 3, 页码: 3881 作者:  Alnaggar, Mohammed[1,2,3];  Qaid, Ammar M.[4];  Chen, Jibing[3];  Niu, Lizhi[3];  Xu, Kecheng[3] 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/13 Cetuximab combined with natural killer cells therapy: an alternative to chemoradiotherapy for patients with advanced non-small cell lung cancer (NSCLC) 期刊论文 2018, 卷号: 8, 期号: 5, 页码: 879 作者:  Liang, Shuzhen[1,2];  Lin, Mao[1,2];  Niu, Lizhi[1,2];  Xu, Kecheng[1,2];  Wang, Xiaohua[1] 收藏  |  浏览/下载：18/0  |  提交时间：2019/12/17 Circulating Tumor DNA as a Sensitive Marker in Patients Undergoing Irreversible Electroporation for Pancreatic Cancer (vol 47, pg 1556, 2018) 期刊论文 2018, 卷号: 48, 期号: 3, 页码: 1397 作者:  Li, Mao[1,2,3,4];  Alnaggar, Mohammed[1,2,5];  Liang, Shuzhen[3];  Chen, Jibing[3];  Xu, Kecheng[3] 收藏  |  浏览/下载：17/0  |  提交时间：2019/12/13 Iodine-125 seed implantation and allogenic natural killer cell immunotherapy for hepatocellular carcinoma after liver transplantation: a case report 期刊论文 2018, 卷号: 11, 页码: 7345 作者:  Xie, Silun[1];  Wu, Zhengyi[1];  Zhou, Liang[2];  Liang, Yingqing[2];  Wang, Xiaohua[2] 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/17 Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome 期刊论文 2018, 卷号: 48, 期号: 5, 页码: 1882 作者:  Alnaggar, Mohammed[1,2,3];  Lin, Mao[4,5];  Mesmar, Adnan[6];  Liang, Shuzhen[5,6];  Qaid, Ammar[3] 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/06 Iodine-125 seed implantation and allogenic natural killer cell immunotherapy for hepatocellular carcinoma after liver transplantation: a case report 期刊论文 ONCOTARGETS AND THERAPY, 2018, 卷号: Vol.11, 页码: 7345-7352 作者:  Xie, Silun;  Wu, Zhengyi;  Zhou, Liang;  Liang, Yingqing;  Wang, Xiaohua 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/26 hepatic  carcinoma  iodine  seeds  implantation  natural  killer  cells  allogenic